What is the Global Gastrointestinal Stromal Tumor (GIST) Treatment Market in 2026?

The global Gastrointestinal Stromal Tumor (GIST) Treatment Market is projected to be valued at US$1,180.8 million in 2026.

What drives the Global Gastrointestinal Stromal Tumor (GIST) Treatment Market?

The increasing prevalence of gastrointestinal stromal tumors worldwide is expanding the patient pool for targeted therapies.

What is the growth rate for the Global Gastrointestinal Stromal Tumor (GIST) Treatment Market?

The global market is poised to witness a CAGR of 6.2% between 2026 and 2033.

What are the key market opportunities?

Combining TKIs with immunotherapy or metabolic inhibitors can overcome resistance and improve outcomes.

Who are the key players in the Global Gastrointestinal Stromal Tumor (GIST) Treatment Market?

Novartis, Pfizer, Bayer AG, Deciphera Pharmaceuticals, Blueprint Medicines, and others.

Table of Content - Gastrointestinal Stromal Tumor (GIST) Treatment Market Size, Share, Growth, and Regional Forecast, 2026 to 2033

Executive Summary
1. Global Gastrointestinal Stromal Tumor (GIST) Treatment Market Snapshot, 2026 and 2033
2. Market Opportunity Assessment, 2026 - 2033, US$ Mn
3. Key Market Trends
4. Future Market Projections
5. Premium Market Insights
6. Industry Developments and Key Market Events
7. PMR Analysis and Recommendations
Market Overview
1. Market Scope and Definition
2. Market Dynamics
  1. Drivers
  2. Restraints
  3. Opportunity
  4. Challenges
  5. Key Trends
3. Macro-Economic Factors
  1. Global Sectorial Outlook
  2. Global GDP Growth Outlook
4. COVID-19 Impact Analysis
5. Forecast Factors - Relevance and Impact
Value Added Insights
1. Drug Adoption Analysis
2. Regulatory Landscape
3. Value Chain Analysis
4. Key Deals and Mergers
5. PESTLE Analysis
6. Porter’s Five Force Analysis
Global Gastrointestinal Stromal Tumor (GIST) Treatment Market Outlook:
1. Key Highlights
  1. Market Size (US$ Mn) and Y-o-Y Growth
  2. Absolute $ Opportunity
2. Market Size (US$ Mn) Analysis and Forecast
  1. Historical Market Size (US$ Mn) Analysis, 2020-2024
  2. Market Size (US$ Mn) Analysis and Forecast, 2026-2033
3. Global Gastrointestinal Stromal Tumor (GIST) Treatment Market Outlook: Drug
  1. Introduction / Key Findings
  2. Historical Market Size (US$ Mn) Analysis, By Drug, 2020 - 2024
  3. Market Size (US$ Mn) Analysis and Forecast, By Drug, 2026 - 2033
    1. Imatinib
    2. Ripretinib
    3. Crenolanib
    4. Regorafenib
    5. Avapritinib
    6. Sunitinib
    7. Others
  4. Market Attractiveness Analysis: Drug
4. Global Gastrointestinal Stromal Tumor (GIST) Treatment Market Outlook: Treatment Type
  1. Introduction / Key Findings
  2. Historical Market Size (US$ Mn) Analysis, By Treatment Type, 2020 - 2024
  3. Market Size (US$ Mn) Analysis and Forecast, By Treatment Type, 2026 - 2033
    1. Targeted Therapy
    2. Immunotherapy
    3. Chemotherapy
    4. Surgery
  4. Market Attractiveness Analysis: Treatment Type
5. Global Gastrointestinal Stromal Tumor (GIST) Treatment Market Outlook: Distribution Channel
  1. Introduction / Key Findings
  2. Historical Market Size (US$ Mn) Analysis, By Distribution Channel, 2020 - 2024
  3. Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2026 - 2033
    1. Hospital Pharmacies
    2. Retail Pharmacies
    3. Online Pharmacies
  4. Market Attractiveness Analysis: Distribution Channel
Global Gastrointestinal Stromal Tumor (GIST) Treatment Market Outlook: Region
1. Key Highlights
2. Historical Market Size (US$ Mn) Analysis, By Region, 2020 - 2024
3. Market Size (US$ Mn) Analysis and Forecast, By Region, 2026 - 2033
  1. North America
  2. Europe
  3. East Asia
  4. South Asia and Oceania
  5. Latin America
  6. Middle East & Africa
4. Market Attractiveness Analysis: Region
North America Gastrointestinal Stromal Tumor (GIST) Treatment Market Outlook:
1. Key Highlights
2. Historical Market Size (US$ Mn) Analysis, By Market, 2020 - 2024
  1. By Country
  2. By Drug
  3. By Treatment Type
  4. By Services
  5. By Distribution Channel
3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2026 - 2033
  1. U.S.
  2. Canada
4. Market Size (US$ Mn) Analysis and Forecast, By Drug, 2026 - 2033
  1. Imatinib
  2. Ripretinib
  3. Crenolanib
  4. Regorafenib
  5. Avapritinib
  6. Sunitinib
  7. Others
5. Market Size (US$ Mn) Analysis and Forecast, By Treatment Type, 2026 - 2033
  1. Targeted Therapy
  2. Immunotherapy
  3. Chemotherapy
  4. Surgery
6. Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2026 - 2033
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
7. Market Attractiveness Analysis
Europe Gastrointestinal Stromal Tumor (GIST) Treatment Market Outlook:
1. Key Highlights
2. Historical Market Size (US$ Mn) Analysis, By Market, 2020 - 2024
  1. By Country
  2. By Drug
  3. By Treatment Type
  4. By Services
  5. By Distribution Channel
3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2026 - 2033
  1. Germany
  2. France
  3. U.K.
  4. Italy
  5. Spain
  6. Russia
  7. Türkiye
  8. Rest of Europe
4. Market Size (US$ Mn) Analysis and Forecast, By Drug, 2026 - 2033
  1. Imatinib
  2. Ripretinib
  3. Crenolanib
  4. Regorafenib
  5. Avapritinib
  6. Sunitinib
  7. Others
5. Market Size (US$ Mn) Analysis and Forecast, By Treatment Type, 2026 - 2033
  1. Targeted Therapy
  2. Immunotherapy
  3. Chemotherapy
  4. Surgery
6. Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2026 - 2033
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
7. Market Attractiveness Analysis
East Asia Gastrointestinal Stromal Tumor (GIST) Treatment Market Outlook:
1. Key Highlights
2. Historical Market Size (US$ Mn) Analysis, By Market, 2020 - 2024
  1. By Country
  2. By Drug
  3. By Treatment Type
  4. By Services
  5. By Distribution Channel
3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2026 - 2033
  1. China
  2. Japan
  3. South Korea
4. Market Size (US$ Mn) Analysis and Forecast, By Drug, 2026 - 2033
  1. Imatinib
  2. Ripretinib
  3. Crenolanib
  4. Regorafenib
  5. Avapritinib
  6. Sunitinib
  7. Others
5. Market Size (US$ Mn) Analysis and Forecast, By Treatment Type, 2026 - 2033
  1. Targeted Therapy
  2. Immunotherapy
  3. Chemotherapy
  4. Surgery
6. Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2026 - 2033
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
7. Market Attractiveness Analysis
South Asia & Oceania Gastrointestinal Stromal Tumor (GIST) Treatment Market Outlook:
1. Key Highlights
2. Historical Market Size (US$ Mn) Analysis, By Market, 2020 - 2024
  1. By Country
  2. By Drug
  3. By Treatment Type
  4. By Services
  5. By Distribution Channel
3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2026 - 2033
  1. India
  2. Southeast Asia
  3. ANZ
  4. Rest of South Asia & Oceania
4. Market Size (US$ Mn) Analysis and Forecast, By Drug, 2026 - 2033
  1. Imatinib
  2. Ripretinib
  3. Crenolanib
  4. Regorafenib
  5. Avapritinib
  6. Sunitinib
  7. Others
5. Market Size (US$ Mn) Analysis and Forecast, By Treatment Type, 2026 - 2033
  1. Targeted Therapy
  2. Immunotherapy
  3. Chemotherapy
  4. Surgery
6. Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2026 - 2033
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
7. Market Attractiveness Analysis
Latin America Gastrointestinal Stromal Tumor (GIST) Treatment Market Outlook:
1. Key Highlights
2. Historical Market Size (US$ Mn) Analysis, By Market, 2020 - 2024
  1. By Country
  2. By Drug
  3. By Treatment Type
  4. By Services
  5. By Distribution Channel
3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2026 - 2033
  1. Brazil
  2. Mexico
  3. Rest of Latin America
4. Market Size (US$ Mn) Analysis and Forecast, By Drug, 2026 - 2033
  1. Imatinib
  2. Ripretinib
  3. Crenolanib
  4. Regorafenib
  5. Avapritinib
  6. Sunitinib
  7. Others
5. Market Size (US$ Mn) Analysis and Forecast, By Treatment Type, 2026 - 2033
  1. Targeted Therapy
  2. Immunotherapy
  3. Chemotherapy
  4. Surgery
6. Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2026 - 2033
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
7. Market Attractiveness Analysis
Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Treatment Market Outlook:
1. Key Highlights
2. Historical Market Size (US$ Mn) Analysis, By Market, 2020 - 2024
  1. By Country
  2. By Drug
  3. By Treatment Type
  4. By Services
  5. By Distribution Channel
3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2026 - 2033
  1. GCC Countries
  2. Egypt
  3. South Africa
  4. Northern Africa
  5. Rest of Middle East & Africa
4. Market Size (US$ Mn) Analysis and Forecast, By Drug, 2026 - 2033
  1. Imatinib
  2. Ripretinib
  3. Crenolanib
  4. Regorafenib
  5. Avapritinib
  6. Sunitinib
  7. Others
5. Market Size (US$ Mn) Analysis and Forecast, By Treatment Type, 2026 - 2033
  1. Targeted Therapy
  2. Immunotherapy
  3. Chemotherapy
  4. Surgery
6. Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2026 - 2033
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
7. Market Attractiveness Analysis
Competition Landscape
1. Market Share Analysis, 2024
2. Market Structure
  1. Competition Intensity Mapping By Market
  2. Competition Dashboard
3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
  1. Novartis
    1. Overview
    2. Segments and Products
    3. Key Financials
    4. Market Developments
    5. Market Strategy
  2. Pfizer
  3. Bayer AG
  4. Deciphera Pharmaceuticals
  5. Blueprint Medicines
  6. Taiho Pharmaceutical
  7. Daiichi Sankyo
  8. Roche
  9. Bristol-Myers Squibb
  10. Others
Appendix
1. Research Methodology
2. Research Assumptions
3. Acronyms and Abbreviations

Gastrointestinal Stromal Tumor (GIST) Treatment Market Size, Share, Growth, and Regional Forecast, 2026 to 2033

Gastrointestinal Stromal Tumor (GIST) Treatment Market by Drugs (Imatinib, Ripretinib, Crenolanib, Regorafenib, Avapritinib, Sunitinib, Others), Treatment Type, Distribution Channel, and Regional Analysis from 2026 to 2033

Quick Links

Our Partners

Secure Payments Through